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Background
Our group has previously described that indirect and
intangible costs substantially burden households with a
food allergic adult. We now extend our investigation to
children and adolescents.
Objective
To estimate the total, direct, indirect and intangible costs
of food allergy, in households with at least one child or
adolescent with objectively-diagnosed allergy to staple
foods (cow’s milk, wheat and/or hen’s egg), and to com-
pare these costs with age- and sex- matched controls.
Methods
Participants included 84 children and 60 adolescents
(cases), and 94 children and 56 adolescents (controls).
Direct and indirect cost data collected via the Food Allergy
Socio-Economic Questionnaire (developed by EuroPrevall)
from parents of children and adolescents with objectively-
diagnosed allergy to staple foods (cases) were compared to
data from age- and sex-matched controls, and calculated
as annual household costs. Total costs were defined as
direct + indirect costs. Direct and indirect costs were also
considered independently. Intangible costs included mea-
sures of self-reported health, standard of living and losses
of well-being.
Results
Annual total household costs were significantly higher for
cases than controls, for children (20,808€ vs. 16,850€,
p<0.05) and adolescents (23,456 € vs. 18,666 €), and were
driven by direct (e.g. medicines) and indirect (e.g. time
spent with health professionals) costs. Children, but not
adolescents, with a history of anaphylaxis had higher
annual direct costs vs. those without anaphylaxis (13,016
€ vs. 10,044€, p<0.05). Intangible costs were greater
amongst cases than controls for both age groups (e.g.
self-reported health p<0.01).
Conclusion
Households with children and adolescents with objec-
tively-diagnosed allergy to staple foods have higher total
household costs than controls. Direct and indirect
household costs were significantly higher for food aller-
gic children, but not food allergic adolescents, compared
to controls. Among both children and adolescents,
objectively-diagnosed allergy to staple foods adversely
impacts intangible costs.
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